Orthosiphon stamineus (OS) is a popular medicinal herb used in traditional Chinese medicine as a diuretic agent and for renal system disorders. This study employed 1 H NMR based metabolomics approach to investigate the possible protective activity of OS in cisplatin induced nephrotoxicity owing to its diuretic and antioxidant activities. Aqueous (OSAE) and 50% aqueous ethanolic (OSFE) extracts of OS leaves were orally administered at 400 mg/kg BW doses to rats which were then intraperitoneally injected with cisplatin at 5 mg/kg BW dose. The 1 H NMR profile of the urine samples collected on day 5 after cisplatin administration were analyzed by multivariate pattern recognition techniques, whereby 19 marker metabolites suggestive in the involvement of TCA cycle, disturbed energy metabolism, altered gut microflora and BCAA metabolism pathways were identified. It was observed that OSFE caused significant changes (p < 0.05) in the levels of 8 markers namely leucine, acetate, hippurate, lysine, valine, 2-oxoglutarate, 3-HBT and acetoacetate resulting in a moderate ameliorative effect, however, it did not completely protect from nephrotoxicity. OSAE did not demonstrate significant down regulatory effects on any markers, albeit, it potentiated the cisplatin nephrotoxicity by inducing significant increase in glucose, glycine, creatinine, citrate, TMAO, acetate and creatine levels. A Principal Component Analysis (PCA) of the 1 H NMR spectra of OS extracts identified that OSFE had higher concentrations of the secondary metabolites such as caffeic acid, chlorogenic acid, protocatechuic acid and orthosiphol, among others. Whereas, OSAE was characterized by higher concentrations of acetate, lactate, succinic acid, valine and phosphatidylcholine. This research denotes the first comprehensive analysis to identify the effects of OS extracts on cisplatin nephrotoxicity.
Introduction
Orthosiphon stamineus Benth (OS) is a medicinal herb used in Traditional Chinese Medicine (TCM) which is widely grown in South East Asia and some parts of the tropical Australia. The leaves of OS have been used due to its various therapeutic effects such as diuretic-hypouricemic [1] , antidiabetic [2] , antihypertensive [3] , and hepatoprotective [4] activities. OS leaves are generally con-sumed in the form of herbal infusion, which is popularly known as Java Tea. Apart from the tea, other forms of OS products such as tablets, capsules, health drinks, raw herbs and dried leaves are also available in the market.
OS is well known for treating ailments of kidney and urinary bladder mainly due to its diuretic action. Owing to the diuretic activity of the Java tea, people have been traditionally using OS for problems of water retention, hypertension, obesity and kidney stones [5] . The French Pharmacopoeia (1974) has listed this plant as for conditions related to renal cleansing and disorders like nephritis, cystitis and urethritis. It is also listed in British Herbal Pharmacopoeia (1996) with a therapeutic indication as diuretic agent. A monograph published in 1996 by the European Scientific Cooperative on Phytotherapy (ESCOP) indicated OS as a remedy in the case of renal inflammation and as an adjuvant in the treatment of bacterial infections of the urinary tract [44] .
The most abundant chemical constituents of OS leaf belong to the chemical classes of terpenoids, polyphenols, flavonoids and sterols [5] . The major chemical constituents isolated from the OS leaves are rosmarinic acid, caffeic acid, cirrchoric acid, sinensetin, eupatorin; mono, di and tri-terpenes, orthosiphols, saponins, organic acids and 3 -hydroxyl-5,6,7,4 -tetramethoxyflavone [6] [7] [8] . Methanolic and hydro alcoholic extracts of OS leaves in vivo in rats exhibited potential diuretic activity [1] . The 50% and 70% aqueous ethanolic tinctures of OS were found to increase the urine volume and sodium excretion [9] . However, a human trial conducted to investigate the acute effects of OS did not record any statistical changes in urine volume or electrolyte excretion [10] . Another study reported that administration of the OS leaves aqueous extract at 5 and 10 mg/Kg body weight increased the urine volume and potassium excretion, but it did not increase the sodium and chloride output [11] . It was also reported that the kidney function parameters were slightly elevated after the treatment with the aqueous extract of OS leaves. The compounds such as sinensetin and 3-hydroxy-5, 6, 7, 4, tetramethoxyflavone isolated from OS were correlated to the increase of urinary volume [12] .
Cisplatin (cDDP; cis-diamminedichloroplatinum II) is an anticancer drug with proven efficiency against different types of solid tumors. Nephrotoxicity, which is the dose limiting side effect of cisplatin, restricts its therapeutic utility. Severe renal impairment is observed in about 25% patients under high dose cisplatin therapy [13] . Cisplatin nephrotoxicity is characterized by tubular damage, mainly affecting the S3 segment of the renal proximal tubule. Currently practiced standard of care in cisplatin nephrotoxicity is continuous hydration with saline and simultaneous administration of mannitol [14] . Efficacy of another diuretic, furosemide, in protecting against cisplatin nephrotoxicity was demonstrated by a randomized trial [15] . Multiple mechanisms are postulated to account for cisplatin nephrotoxicity, among which oxidative stress through the mediation of reactive oxygen species is considered to be one of the most important [16] . The beneficial effects of antioxidant supplements such as vitamin E [17] , vitamin C [18] and melatonin [19] have been proven in the animal studies and are currently in use as supportive measures. OS was reported previously to possess strong antioxidant and free radical scavenging activities [4, 7, 20] . Thus, this study was designed to investigate the impact of synergistic effects of diuretic activity coupled with antioxidant and free radical scavenging properties of OS on protection against cisplatin induced nephrotoxicity.
Metabolomics has recently emerged as an explorative application in the field of pharmacology and toxicology, since it has been proven to be a quick and reproducible method in directly demonstrating the biological events [21] . This tool involves the determination of changes in the levels of endogenous or exogenous metabolites in biological samples, owing to physiological stimuli or genetic modification [22] . The strength of metabolomics lies in the global determination of metabolites, or patterns of biomarkers that altered as the result of a stimulus [23] .
A natural product might contain hundreds of small chemical constituents, where even tracer amounts of a particular compound can exert certain biological activity by itself or sometimes in a synergistic action with other components. On a similar note, possibilities of antagonism and selective inhibition of activity also arises in such a complex matrix of chemical compounds [24] . Further to this, the variations caused by the preprocessing methods and variables in extraction steps of natural products make the traditional medicine research challenging. Metabolomics provides a unique platform to identify all such interactions comprehensively in a single experiment, and which marks the most important advantage of metabolomics over conventional method of pharmacological screening. Although many kinds of advanced instrumental approaches could be utilized in metabolomics studies, Nuclear Magnetic Resonance (NMR) spectroscopy is one of the most preferred methods as it relies on simple sample preparation, handling and data analysis techniques [25] . The recorded NMR spectra are statistically compared and the patterns are visualized using unsupervised clustering of Principal Component Analysis (PCA) or the supervised classification of Partial Least Squares Discriminant Analysis (PLS-DA) and Orthogonal Partial Least Squares Discriminant Analysis (OPLS DA) method [26] . In this study, metabolic alterations caused by cisplatin nephrotoxicity were investigated and the effect of OS on the altered metabolite pattern was analyzed. Metabolomics, as a global and comprehensive technique to visualize and understand all the metabolite alterations in a single snap shot has given a clear understanding of the OS effects on various markers of cisplatin induced nephrotoxicity as hereby described.
Materials & methods

Plant material, chemicals and reagents
OS leaves of same age grown under same environmental, geographic and growth conditions were collected from Taiping (GPS coordinates: 4.52 • N, 100.48 • E), Perak, Malaysia in January 2012. The plant sample was authenticated by the botanist at Unit of Biodiversity, Institute of Bioscience, Universiti Putra Malaysia and a voucher specimen (SK1997/12) was deposited at the unit herbarium.
3-Trimethylsilylpropionic acid (TSP) was purchased from Sigma Aldrich (St. Louis, USA). Deuterated methanol (CD 3 OD, 99.9%), deuterium oxide (D 2 O, 99.9%) and deuterated sodium hydroxide, potassium dihydrogren phosphate, absolute ethanol and sodium azide were purchased from Merck (Darmstadt, Germany). Ultrapure distilled water of a Sartorius Stedim (Göttingen, Germany) purification system was used. The normal rat chow feed was purchased from Specialty feeds (Glen Forrest, Australia). Cisplatin injection was purchased from Hospira Australia (Mulgrave, Australia). Standard diagnostic kits for the determination of urea and creatinine were purchased from Roche diagnostics (Stockholm, Sweden).
Extraction
The freshly collected leaves were dried under shade for 14 days at room temperature. The dried leaf material was pulverized, sieved and stored in airtight plastic containers at 3 ± 2 • C until further use. Aqueous and 50% aqueous ethanolic extracts of OS leaf material (OSAE and OSFE respectively) were prepared by ultrasonic assisted extraction method. Plant sample with measured amount (1 g:20 mL) of solvent was subjected to sonication for 30 min, maintaining the water bath at constant ambient temperature of 25 • C. The extract was filtered before another two more separate repeated extractions were done with fresh solvent and sonication steps. The filtrate was combined and the solvent was removed using rotary evaporator which resulted in a crude extract for each which was then freeze dried and stored at −80 • C until further use.
Phytochemical analysis of the OS extracts
Two major marker compounds of OS, namely sinensetin and rosmarinic acid were quantified using a Shimadzu LC-20AD High Performance Liquid Chromatography system (Shimadzu Corporation, Kyoto, Japan) according to a previously reported isocratic elution method with slight modifications [27] . A solvent mixture comprised of acetonitrile: isopropanol: 20 mM phosphate buffer (30:15:55 v/v) with pH adjusted to 3.5 using 85% formic acid at a flow rate of 0.8 mL/min was used as the mobile phase. The injection volume was 10 L. A Zorbax C18 column of 150 mm × 4.6 mm × 5 m achieved the separation at room temperature and a UV detector recorded the peaks at a wavelength of 340 nm. Standard solutions of the sinensetin and rosmarinic acid (Indofine Chemicals, USA) in concentrations of 50, 10, 5, 1 and 0.1 ppm were used to obtain the calibration curve.
Animals
All the animal experiments were conducted in Animal Biosafety Level -2 (ABSL -2) housing complex located at Laboratory of Animal Resource, Universiti Kebangsaan Malaysia (Bangi, Malaysia). In house bred adult male Sprague Dawley rats of eight weeks old, weighing 230-270 g were used in the study. The rats were held in air conditioned room at 24 ± 2 • C on a 12/12 h light-dark cycle. Three rats were housed per polycarbonate cage and had free access to rodent chow and water. All rats were acclimatized to the laboratory condition for a period of one week prior to dosing. All the animal experimental protocols were approved by Animal Care and Use Committee (ACUC), Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (Approval number: UPM/FPSK/PADS/BR-UUH/00460). All efforts were made to minimize suffering and distress of rats.
Sample administration and urine collection
The rats were randomly divided into six experimental groups of 6 animals each. Groups 1-4 served as the control for normal (CON), cisplatin (CIS) and OS extracts (OSAE and OSFE). The treatment groups 5 and 6 were fed with OS leaf extracts at a dose of 400 mg/kg body weight through oral gavage once daily for 6 days prior and 4 days after the cisplatin administration which was administered by single intraperitoneal injection of 5 mg/kg BW.
On the 4th day after administering the cisplatin, the rats were individually housed in metabolic cages and overnight urine samples were collected in tubes containing 0.1% w/v of sodium azide to prevent microbial growth. During the stay in the metabolic cages, the rats were deprived of food to avoid contamination of urine from the solid food debris, but allowed water ad libitum. The collected urine samples were stored at −80 • C until analysis.
Histopathological evaluation
On day 5 after cisplatin administration, the rats were euthanized and the kidneys were harvested for histopathological examination. The organ was then fixed in 10% formalin. The fixed tissues were embedded and cut into 5 m thick sections. The hematoxylin and eosin stained sections were observed and photographed under a light microscope. Five random areas from each section were examined and quantitative scores of protein casts, cellular degeneration and necrosis and cellular casts representing the renal damage were determined.
NMR spectroscopic analysis
Urine samples were thawed and centrifuged (5000 rpm, 10 min, and room temperature) to remove any precipitates. In order to obtain the 1 H NMR spectra of crude extracts, 20 mg of the extracts were placed in 2 mL Eppendorf tubes and 0.5 mL each of CD 3 OD and KH 2 PO 4 buffer in D 2 O (pH 6.0) containing 0.1% TSP were added. The mixture was vortexed for 1 min followed by ultrasonication for 15 min at room temperature (25 • C). The mixture was then centrifuged at 13000 rpm for 10 min to obtain a clear supernatant, and then 0.6 mL of it was transferred to a NMR tube for analysis [28] .
The 1 H NMR spectra of the samples were recorded using Varian INOVA 500 MHz instrument with an operating frequency of 499.91 MHz at 25 • C with a pulse width (PW) of 21.0 s and a relaxation delay (RD) of 2 s. Deuterium oxide was used as the internal lock solvent and the residual solvent peak was suppressed using a 64 scan PRESAT sequence, with a total acquisition time of 3.53 min. The reference standard used was 0.1% TSP.
The 2D NMR spectra such as J resolved (JRES), COSY and HMBC were acquired using Bruker Ascend 700 MHz instrument at room temperature (25 • C). The JRES and COSY spectra were acquired using 4 scans, 1 K data points at 128 increments and a spectral width of 16 ppm in dimensions and a relaxation delay of 2 s. The heteronuclear multiple bond coherence (HMBC) spectra were obtained using 8 scans, 1 K data points, 256 t1 increments at spectral width of 13 ppm and 220 ppm in the proton and carbon dimensions respectively. The relaxation delay was 1.5 s.
Pre-processing of NMR spectra
All raw 1 H NMR spectra were manually phased, baseline corrected and referenced to the internal standard (TSP) at 0.00 ppm using Chenomx NMR Suite 5.1 Professional (Edmonton, Canada). The chemical shift region of 0.0-10.0 ppm was reduced to integrated regions of width 0.04 ppm using Chenomx software. The spectral region related to residual water (4.52-4.92) was removed from the analysis. Normalization of the remaining spectral segments was carried out to the total sum of the spectral intensity, which partially compensates for differences in the metabolite concentrations of the samples. The obtained binned data was then subjected to multivariate data analysis using SIMCA-P 13.0 (Umetrics, Umea • , Sweden). The relative concentration of the metabolites was determined using the 500 MHz library from Chenomx NMR Suite 7.7. The univariate analysis of the metabolite integration area was also performed.
Pareto scaling was applied on the mean centered data before performing Orthogonal Partial Least Squares-Discriminant Analysis (OPLS-DA). The score plot generated from the data aided to visualize the clustering pattern of the urine samples along two principal components (PC1 and PC2), wherein each point denoted an individual spectrum of a urine sample. The loading plots indicated the metabolites responsible for the group separation, wherein each dot represented an individual bin of the 1 H NMR spectrum. The validation and fitting of the models were assessed by three fold methods of 100 permutation test, calculation of R2Y, Q2Y and CV-ANOVA values [29] .
Statistical analysis
All data were expressed as mean ± SEM. Kolmogorov-Smirnov test was applied to check the normality of the distribution. If the normality was assumed, a parametric One-way analysis of variance (ANOVA) was performed; otherwise, non-parametric Kruskal Wallis test was applied, using GraphPad Prism V 6.0 (GraphPad Software Inc, San Diego, USA); Dunnett's test was chosen as post hoc analysis method wherein p < 0.05 was considered to be statistically significant. 
Results and discussion
In this study, the 1 H NMR-based metabolomics approach was applied to assess the potential of OS, a popular herb which is used in traditional Chinese medicine as a diuretic and renal protective agent, in ameliorating the nephrotoxicity induced by cisplatin. OPLS-DA analyses of the 1 H NMR profiles of urine samples revealed the potential biomarkers of cisplatin induced nephrotoxicity and the metabolic alterations brought about by OS in affected metabolic pathways. The study established that the 50% aqueous ethanolic extract (OSFE) exhibited ameliorative activity, whereas the aqueous extract of OS (OSAE) had a deteriorative effect on the toxicity induced by cisplatin. It reinforced the role of a global and comprehensive analysis of the traditionally used natural product extracts to ensure their safe usage in any disease conditions and also not to miss out any interesting clues towards the discovery of a potential lead.
Phytochemical analysis
The levels of two marker compounds of OS, namely sinensetin and rosmarinic acid, were determined by HPLC quantification method. The contents of sinensetin in OSAE and OSFE was 0.25 and 0.30%, respectively. The rosmarinic acid content in OSFE was 37.66%, however, it was not detected in OSAE.
Histopathological evaluation
The control, OSAE and OSFE rat kidneys were characterized by normal architecture of cells in both cortical and medullary areas (Fig. 1A-C) . The cisplatin treated rat kidney (Fig. 1D ) recorded severe tubular injury as revealed by a hydrophic degeneration and necrosis of the tubules. The necrotic cells were characterized by the presence of numerous pyknotic nuclei, karyolytic nuclei and/or eosinophilic cytoplasm of the renal tubular epithelial cells. Some of the renal tubules were severely affected where sloughing of the renal tubular epithelial cells were observed, indicated as dilated tubules, leading to the formation of renal cellular and/or granular casts in the tubules. The damage of the renal tubular epithelial cells led to sequestration of protein from the blood vessels into the renal tubules leading to the formation of protein casts indicated by the presence of homogenous eosinophilic protein matrix in the renal tubules. Result showed severe renal tubular damage was induced by cisplatin, however it only causes minimal histopathological alterations in the glomeruli. Marked infiltration of inflammatory cells was also evident in both renal cortex and medulla of the cisplatin treated rat kidneys. The CIS + OSFE treated rat kidneys' (Fig. 1F) showed a slight reduction in the severity of the lesions (protein and cellular casts' deposition and necrosis), but the lesions were scored significantly less severe compared to the cisplatin rats. This suggesting that the OSFE treatment could partly control the progression of renal damage induced by cisplatin. However, CIS + OSAE treated kidney tissue (Fig. 1E ) did not record any statistically significant changes in the histopathological lesions. A quantitative scoring of the histological lesions is shown in Fig. 1G. 
Urinary metabolic profiling of cisplatin induced nephrotoxic rats
Representative 500 MHz 1 H NMR spectra of the rats and 5 mg/kg BW induced cisplatin nephrotoxic rats urine samples collected on day 5 after cisplatin administration are shown in Fig. 2a and d . Identification of the metabolites were based on 1D NMR chemical shifts reported in the literature, aided by Chenomx NMR suite 7.7 (Chenomx Inc., Edmonton, Canada) and through querying open access metabolomics databases such as Human Metabolome Database (HMDB, http://www.hmdb.ca), Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.kegg.jp) and finally confirmed by J resolved NMR and two-dimensional NMR experiments such as COSY ( 1 H-1 H correlation spectroscopy) and HMBC ( 1 H-13 C Heteronuclear multiple bond correlation). Visual inspection of the 1 H NMR spectra of control (CON) and cisplatin (CIS) rats urine (Fig. 2) clearly indicated that chemical shift region 3-6 ppm which mainly constituted of carbohydrate/sugar moieties was the most affected. Followed by region of 1-3 ppm which mainly represented the aliphatic group. This indicated that carbohydrates and amino acids were the most affected metabolite classes in cisplatin nephrotoxicity.
OPLS-DA analysis was carried out on urine 1 H NMR data of CON and cisplatin CIS groups' rats collected on day 5 after the cisplatin administration to investigate the metabolite alterations induced and thereby to determine the biomarkers. The goodness of fit and predictability for the model was reflected by values of R2Y = 0.986 and Q2Y = 0.963. CV-ANOVA value of 3.78e-009 reconfirmed the validity of the model. The OPLS-DA score plot (Fig. 3a) clearly discriminated CON and CIS rats' urine samples, wherein X-and Y-axis represented PC1 and PC2 respectively and each point in the score plot represented sample from one rat. The CON and CIS group clustered separately along PC1.
The loading column plot with 95% jack and knife bars was sorted to identify the characteristic variables responsible for the class separation, whereby this information was combined with the S-plot 1 H NMR urine spectra of (a) Normal rat (b) OSAE rat (c) OSFE rat (d) Cisplatin control rat (e) CIS + OSAE rat (f) CIS + OSFE rat, labeled with identified metabolites: (1) Leucine (2) Valine (3) 3-Hydroxy butyrate (4) Lactate (5) Alanine (6) Lysine (7) Acetate (8) Acetoacetate (9) Pyruvate (10) Citrate (11) Methylamine (12) Dimethylamine (13) Creatine (14) Creatinine (15) and VIP (Variable Important in Projection) plot of OPLS-DA to establish the biomarkers (Fig. S1 , Table S1 and S2). Metabolite variation could be distinguished by the loading plot (Fig. 3b) color coded according to the absolute value of correlation coefficients, where a hot-colored signal (red) indicated more significant contribution to the class separation than a cold-colored one (blue). The positive side of the loading plot constituted metabolites increased in the CON group (down regulated): allantoin, urea, creatinine, 2-oxoglutarate, Fig. 3 . OPLS-DA analysis of the urine metabolic profiles between CON and CIS rats. Score plot (A) and color coded coefficient loading plot (B) for 1 H NMR spectra of urine on day 5 after cisplatin administration (R2Y = 0.986, Q2Y = 0.963). Red colored circles and blue colored triangles represented the CIS and CON groups respectively. Metabolites in urine labeled 1, valine; 2, 3-HBT; 3, lactate; 4, alanine; 5, lysine; 6, acetate; 7, N-acetylglycine; 8, acetoacetate; 9, 2-oxoglutarate; 10, citrate; 11, creatinine; 12, glucose; 13, creatine; 14, allantoin; 15, urea; 16, 3-indoxylsulfate; 17, hippurate. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) dimethylamine, and citrate; whereas the negative side constituted metabolites increased in the CIS nephrotoxic group (up regulated): glucose, 3-hydroxybutyrate, lactate, creatine, glycine, acetoacetate, trimethylamine N-oxide (TMAO), acetate, lysine, alanine, valine and leucine. The relative quantification of these putative biomarkers was carried out and their fold change values with associated p-values are shown in Table 1 . The metabolite changes in mouse urine on day 2 after a single injection of 20 mg/kg body weight cisplatin was reported as increased levels of glucose, alanine, lactate, leucine, methionine, pyruvate and valine [30] . The increased level of 2-oxoglutarate on day 2 witnessed a fall in days 3-4, which is in par with the findings of the current study. However, it was found that, unlike day 2, the methionine level was not significantly different between the CIS and CON groups on day 5.
Metabolite alterations induced by OS treatment in cisplatin nephrotoxicity
OPLS-DA analysis was carried out on urine 1 H NMR data of rats in the CON, OS extracts, CIS, CIS + OS treatment groups collected on day 5 after cisplatin administration to investigate the effect of OS leaves extract in cisplatin nephrotoxicity. The CIS and OS treated Metabolites in urine were labeled; 1, 3-HBT; 2, acetate; 3, 2-oxoglutarate; 4, citrate; 5, glucose; 6, glycine; 7, creatine; 8, creatinine; 9, allantoin; 10, urea; 11, hippurate. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) groups were clustered separately as given by the score plots ( for OSFE, respectively revealed satisfactory goodness of fit and predictability of the models. The fold changes caused by OS treatment in the levels of all metabolite biomarkers identified in cisplatin nephrotoxicity were further calculated and their statistical significance is shown in Table 1 .
OSFE brought about significant ameliorative effects on certain markers of cisplatin nephrotoxicity. The most significantly reduced metabolites include leucine, acetate, valine, 3-HBT and acetoacetate (Fig. 4D) . Urinary levels of currently relied biomarkers on nephrotoxicity such as creatinine and urea were also slightly reduced by OSFE. The aqueous extract (OSAE) used in this study finds particular importance since the main mode of consumption of OS is as an infusion, prepared by boiling dried leaves in water. We found that cisplatin nephrotoxicity was worsened, but not inhibited, by the treatment with OSAE. From Table 1 , it could be noted that the levels of creatinine and glucose recorded nearly 40% increase compared to CIS rats. Other major biomarkers of cisplatin nephrotoxicity such as glycine, acetate, TMAO and creatine were also raised in statistically significant manner compared to CIS (Fig. 4B) .
Many previous studies reported glycosuria as a typical biomarker for acute renal toxicity [31, 32] . In our study it was found that urinary glucose was significantly increased by 6 fold on day 5 after cisplatin administration. The presence of glycosuria indicated at the proximal tubule injury [30] , which is the primary site of cisplatin nephrotoxicity. OSAE administration led to 40% rise in the glucose levels compared with CIS, whereas OSFE caused slight reduction. The cisplatin administration triggered a raise in the levels of acetate and lactate, whereas those of 2-oxoglutarate and citrate were reduced. These metabolites are the intermediates of tricarboxylic acid (TCA) cycle (Fig. 5 ) and hence this observation directed at inhibition of TCA cycle and thereby impairing the energy metabolism [33] . OSFE has partly reduced the levels of acetate and lactate and increased the levels of citrate, suggesting that the TCA cycle was partly normalized. However, the levels of 2-oxoglutarate was slightly decreased.
The altered levels of TMAO and dimethylamine indicated a disturbance in methylamine metabolism. Methylamines are produced by the degradation of dietary choline to trimethylamine and its di and monoamine metabolites by gut microflora [34] . An alternative route of production of polyamines was proposed as the breakdown of choline into betaine and dimethylglycine. It was observed in an earlier study that the reduced population of gut microflora causes the relative increase of betaine over TMAO and dimethylamine [35] . However, since the major betaine peaks overlap with those from glucose, we did not include it in the analysis. Increased levels of TMAO and dimethylamine as a result of increased choline degradation may be a reflection of alterations in gut microflora. The TMAO level was further raised by 54% with the administration of OSAE, which hinted at the possible aggravation of gut microbiota disturbance. It was also observed during the study that the CIS treated rats' recorded progressive loss of weight against the weight gain of CON rats, starting from 24 h after cisplatin administration, which could be correlated with the gastrointestinal toxicity induced by cisplatin [17] .
Significantly increased levels of ketone bodies such as 3-hydroxy butyrate and acetoacetate were noted. This pointed at the stalling of TCA cycle and a shift of glucose oxidation towards beta oxidation of fatty acids, which is a clear indicative of disturbance in energy metabolism [36] . The OSFE has significantly lowered the concentration of acetoacetate and 3-HBT, whereas OSAE caused rise of both metabolites levels. An increased level of glycine coupled with low level of hippurate could be directly correlated, as the hippurate is formed from the precursors benzoate and glycine mediated by ATP [37] . This could have risen due to the deficiency of ATP, which could be due to the inhibition of TCA cycle as was evident in from the reduction of TCA cycle intermediates. OSFE treatment has caused the hippurate level to be increased, probably as a result of 1 H NMR metabolomics in rat urine. Metabolites in pink and blue backgrounds represent a statistically significant increase and decrease in urinary levels, respectively. The metabolite levels that were significantly altered by the OS treatment on day 5 after cisplatin administration were shown as box plots with values expressed as mean ± SEM, A and F represented OSAE and OSFE respectively. **p < 0.01, *p < 0.05 for CIS + OS vs. CIS rats. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) reactivation of TCA cycle as evident from the metabolite (acetate, lactate, and citrate) alterations discussed above.
Hence, it could be summarized from the present study that pre and concomitant administration of OS extracts was not effective enough to afford complete protection of the kidneys from toxicity induced by cisplatin. The OSFE treatment was partly able to control the progression of nephrotoxicity by altering the intermediate metabolite levels of various pathways such as sugar and carbohydrate metabolism, ketogenesis and TCA cycle. However, as it was evident, the metabolite alterations caused by OSAE treatment contributed in further damage to the kidneys. Generally followed acute and sub chronic toxicity tests on animals ruled out the toxicity of OS and declared their safety in kidney function parameters [38] [39] [40] . However, one previous study has revealed that an aqueous extract of OS caused statistically significant increase, yet within normal range, in the levels of serum urea, creatinine and blood glucose [11] .
PCA analysis of the OS extracts
A Principal Component Analysis (PCA) was carried out on the 1 H NMR spectra of OSAE & OSFE in order to identify the differences in plant metabolite profile which might be responsible for the differential effects on cisplatin nephrotoxicity. The generated two component PCA model had optimum goodness of fit and predictability as evident from the parameters of R2 = 0.943 and Q2 = 0.888, respectively. Fig. 6a depicts the score plot, wherein the component 1 and 2 respectively explained 89.1% and 5.2% of the total variation. The OSAE was separated from the OSFE samples by component 1 hinting at their different metabolic profiles. The loading plot shown in Fig. 6b represents the variables responsible for the class separation between OSAE & OSFE samples as given by component 1. The metabolites marked on the negative side of the loading plot are present in higher concentrations in OSFE compared to OSAE. Likewise, the metabolites marked on the positive side of the loading plot are present in higher concentrations in OSAE compared to OSFE. OSFE had higher concentrations of the secondary metabolites such as caffeic acid, chlorogenic acid, protocatechuic acid and orthosiphol. The phenylpropanoid compounds were identified by their characteristic peaks at ı 6.30 (d, J = 15.9 Hz), ı 6.87 (d, J = 8.2 Hz), ı 7.06 (dd, J = 8.5,1.6 Hz), ı 7.11 (d, J = 1.8 Hz), ı 7.52 (d, J = 15.9 Hz) for caffeic acid; chlorogenic acid, which differs from caffeic acid only by the presence of a characteristic peak at ı 5.36 (m), and protocatechuic acid with characteristic peaks at ı 6.77 (d, [41] . The characteristic peaks for orthosiphol analogues included a number of doublets in the spectral region of ı 5.55 to ı 6.0 and between ı 3.8 to ı 4.1 with J values between 2.6-3.0 Hz and a signal at ı 2.97 (dd, J = 14.3, 4 Hz) [42, 43] . Other discriminatory metabolites identified to be in higher concentrations in OSFE included choline, aspartic acid, ˇ glucose and sucrose. OSAE had higher concentrations of acetate, lactate, succinic acid, valine and phosphatidylcholine than OSFE. The levels of these differential metabolites were determined in order to gain an insight into their variances. The relative quantification performed using the 1 H NMR bin area of the most abundant signal of the respective metabolite was shown in Fig. 7 .
Conclusion
Consumption of natural products remains a popular and first line method among the folk in the prevention as well as treatment of various ailments. Though a particular natural product is known for its protective effect in a particular system, it is highly recommended to validate the safety and efficacy against specific objective of its usage. In this study, 1 H NMR metabolomics approach was used to study the effects of a popular renal-protective diuretic agent OS in cisplatin induced nephrotoxicity. To the best of our knowledge, this is the first comprehensive analysis to identify the effects of OS extracts on cisplatin nephrotoxicity. It was found that 50% aqueous ethanolic extract of OS leaves (OSFE) had higher concentration of biologically active secondary metabolites and hence a moderate ameliorative effect was exhibited, yet failed to give a complete protection. However, the aqueous extract of OS leaves (OSAE) exhibited slightly deteriorative activity by disturbing the energy metabolism and gut microflora. The metabolomics approach identified the effects of OS in every biomarker of cisplatin nephrotoxicity and thus provided a platform for better exploration and understanding, and proved as a promising tool in the traditional medicine research.
